Highlights Synmosa Biopharma Corporation

Equities

4114

TW0004114004

End-of-day quote Taipei Exchange Other stock markets 03:30:00 28/06/2024 am IST			5-day change	1st Jan Change
41.15 ^TWD	-0.48%		-0.60%	+6.47%

15/05	Synmosa Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
29/03	Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Synmosa Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05	CI
Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	29/03	CI
Synmosa Biopharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11	CI
Synmosa Biopharma Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/23/11	CI
Synmosa Biopharma Corporation Announces Cash Dividend, Payable on September 15, 2023	24/23/24	CI
Synmosa Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	31/23/31	CI
Synmosa Biopharma Corporation Approves Dividend for the Year Ended December 31, 2022	13/23/13	CI
Synmosa Biopharma Corporation Provides Earnings Guidance for the Year 2022	28/22/28	CI
Synmosa Biopharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	12/22/12	CI
Synmosa Biopharma Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/22/12	CI
Synmosa Biopharma Corporation Announces Cash Dividends, Payable on August 15, 2022	22/22/22	CI
Tranche Update on Synmosa Biopharma Corporation's Equity Buyback Plan announced on March 29, 2022.	13/22/13	CI
Synmosa Biopharma Corporation's Equity Buyback announced on May 29, 2022, has closed with 4,000,000 shares, representing 1.35% for TWD 108.97 million.	13/22/13	CI
Synmosa Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	13/22/13	CI
Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	30/22/30	CI
Synmosa Biopharma Corporation announces an Equity Buyback for 4,000,000 shares, for TWD 1,177.47 million.	29/22/29	CI
Synmosa Biopharma Corporation authorizes a Buyback Plan.	29/22/29	CI
Synmosa Biopharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	10/21/10	CI
Synmosa Biopharma Corporation Announces Cash Dividend for 2020, Payable on October 28, 2021	06/21/06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Synmosa Biopharma Corporation

Equities

4114

TW0004114004

Highlights

Filters